Side-by-side comparison

MOTS-c

Metabolic PeptideSafety 7/10

Mitochondrial research

vs

5-Amino-1MQ

Metabolic Small MoleculeSafety 6/10

Lipolysis / metabolic research

MOTS-c
5-Amino-1MQ
Cheapest price
$25.55 /10mg
$4.00 /5mg
Vendors stocking
33
18
Safety rating
7/10
6/10
Mol. weight
2,174.6 g/mol
159.21 g/mol (cation) / 286.11 g/mol (iodide salt)
Administration
Subcutaneous injection
Oral

Price Comparison — 2026

MOTS-c

VendorPrice
Alpha Peptides$25.55 /10mgBuy →
Puratek Peptides$26.96 /10mgBuy →
Hydro Research$28.00 /10mgBuy →
Ascension Peptides$30.00 /10mgBuy →
Novatherix Laboratories$31.50 /10mgBuy →

5-Amino-1MQ

VendorPrice
Hydro Research$4.00 /5mgBuy →
SomaChems$6.40 /5mgBuy →
Midwest Peptide$11.25 /5mgBuy →
Peptira$12.90 /5mgBuy →
Puratek Peptides$15.73 /5mgBuy →
Ascension Peptides$18.75 /5mgBuy →

Vendors Carrying Both

18 vendors stock both MOTS-c and 5-Amino-1MQ — convenient if you want to bundle an order.

Hydro ResearchMOTS-c: $28.005-Amino-1MQ: $4.00Visit →
SomaChemsMOTS-c: $43.995-Amino-1MQ: $6.40Visit →
Midwest PeptideMOTS-c: $40.495-Amino-1MQ: $11.25Visit →
PeptiraMOTS-c: $34.755-Amino-1MQ: $12.90Visit →
Puratek PeptidesMOTS-c: $26.965-Amino-1MQ: $15.73Visit →
Ascension PeptidesMOTS-c: $30.005-Amino-1MQ: $18.75Visit →
Licensed PeptidesMOTS-c: $42.505-Amino-1MQ: $18.90Visit →
Polar PeptidesMOTS-c: $36.005-Amino-1MQ: $25.20Visit →
Optimum FormulaMOTS-c: $40.495-Amino-1MQ: $31.49Visit →
Pinnacle Peptide LabsMOTS-c: $59.495-Amino-1MQ: $33.99Visit →
BioLongevity LabsMOTS-c: $109.975-Amino-1MQ: $37.48Visit →
Liv Pure WellnessMOTS-c: $30.005-Amino-1MQ: $39.50Visit →
Amino ClubMOTS-c: $31.995-Amino-1MQ: $39.99Visit →
Olympex SolutionsMOTS-c: $44.995-Amino-1MQ: $49.99Visit →
LA PeptidesMOTS-c: $69.995-Amino-1MQ: $55.99Visit →
PeptuviaMOTS-c: $70.005-Amino-1MQ: $59.00Visit →
Pantheon PeptidesMOTS-c: $50.545-Amino-1MQ: $81.00Visit →
LeoLab RxMOTS-c: $105.005-Amino-1MQ: $110.00Visit →

Safety Notes

MOTS-c

FDA: Not FDA-approved

Endogenous mitochondrial peptide; human study showed safety in metabolic syndrome; promising early data

5-Amino-1MQ

FDA: Not FDA-approved

Experimental NNMT inhibitor; animal data favorable; no major safety signals identified; WADA banned

Failed to fetch